Proline-rich sequence recognition domains (PRD): Ligands, function and inhibition

32Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Low-affinity protein-protein interactions (PPI) between domains of modular proteins and short, solvent-exposed peptide sequences within their binding partners play an essential role in intracellular signaling. An important class of PPIs comprises proline-rich motifs (PRM) that are specifically recognized by PRM-binding domains (PRD). Aromatic side chains of the PRDs define the binding pockets that often recognize individual proline residues, while flanking sequences mediate specificity. Several of these PRM:PRD interactions are associated with cellular malfunction, cancer or infectious diseases. Thus, the design of PRM:PRD inhibitors by using structure-based molecular modeling as well as peptidomimetic approaches and high-throughput screening strategies is of great pharmacological interest. In this chapter we describe the molecular basis of PRM:PRD interactions, highlight their functional role in certain cellular processes and give an overview of recent strategies of inhibitor design. © 2008 Springer Berlin Heidelberg.

Cite

CITATION STYLE

APA

Freund, C., Schmalz, H. G., Sticht, J., & Kühne, R. (2008). Proline-rich sequence recognition domains (PRD): Ligands, function and inhibition. Handbook of Experimental Pharmacology, 186, 407–429. https://doi.org/10.1007/978-3-540-72843-6_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free